Zobrazeno 1 - 10
of 70
pro vyhledávání: '"MESH : Interferon-alpha"'
Autor:
Olivia Blake, Arnaud Droit, Alexandre Nicolas, Jérôme Estaquier, Alexandra Tauzin, Armando Espinosa Ortiz, Jacques Dutrieux, Calaiselvy Soundaramourty, Fabrizio Mammano, Charles Joly-Beauparlant
Publikováno v:
Journal of Virology
Journal of Virology, 2021, 95 (15), pp.e0231120. ⟨10.1128/JVI.02311-20⟩
J Virol
Journal of Virology, American Society for Microbiology, 2021, 95 (15), pp.e0231120. ⟨10.1128/JVI.02311-20⟩
Journal of Virology, 2021, 95 (15), pp.e0231120. ⟨10.1128/JVI.02311-20⟩
J Virol
Journal of Virology, American Society for Microbiology, 2021, 95 (15), pp.e0231120. ⟨10.1128/JVI.02311-20⟩
International audience; Type I interferons (IFNs) are a family of cytokines that represent a first line of defense against virus infections. The 12 different IFN-α subtypes share a receptor on target cells and trigger similar signaling cascades. Sev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2043d318193f130e04b6e434b3ee6a22
https://www.hal.inserm.fr/inserm-03451787/document
https://www.hal.inserm.fr/inserm-03451787/document
Autor:
Jens Bohne, Daniel Todt, Steppich K, Sergej Franz, Angelina Malassa, Thomas Zillinger, Eike Steinmann, Xu S, Nicoletta Casartelli, Passos, Christine Goffinet, Winfried Barchet, Wachs As, Oliver Schwartz, Schilling H, Kathrin Sutter, Ulf Dittmer
Publikováno v:
Journal of Virology
Journal of Virology, American Society for Microbiology, 2019, 93 (24), pp.e01221-19. ⟨10.1128/JVI.01221-19⟩
Journal of Virology, 2019, 93 (24), pp.e01221-19. ⟨10.1128/JVI.01221-19⟩
Journal of virology
Journal of Virology, American Society for Microbiology, 2019, 93 (24), pp.e01221-19. ⟨10.1128/JVI.01221-19⟩
Journal of Virology, 2019, 93 (24), pp.e01221-19. ⟨10.1128/JVI.01221-19⟩
Journal of virology
SERINC5 is the long-searched-for antiviral factor that is counteracted by the HIV-1 accessory gene product Nef. Here, we engineered, via CRISPR/Cas9 technology, T-cell lines that express endogenous SERINC5 alleles tagged with a knocked-in HA epitope.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5306d95cc3510117e1b8d2cd7c2984
https://hal-pasteur.archives-ouvertes.fr/pasteur-03253574/file/JVI.01221-19.pdf
https://hal-pasteur.archives-ouvertes.fr/pasteur-03253574/file/JVI.01221-19.pdf
Autor:
Madelain, Vincent, Baize, Sylvain, Jacquot, Frédéric, Reynard, Stéphanie, Fizet, Alexandra, Barron, Stephane, Solas, Caroline, Lacarelle, Bruno, Carbonnelle, Caroline, Mentré, France, Raoul, Hervé, de Lamballerie, Xavier, Guedj, Jérémie
Publikováno v:
Nature Communications
Nature Communications, 2018, 9 (1), pp.4013. ⟨10.1038/s41467-018-06215-z⟩
Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Nature Communications, Nature Publishing Group, 2018, 9, ⟨10.1038/s41467-018-06215-z⟩
Nature Communications, Nature Publishing Group, 2018, 9 (1), pp.4013. ⟨10.1038/s41467-018-06215-z⟩
Nature Communications, 2018, 9 (1), pp.4013. ⟨10.1038/s41467-018-06215-z⟩
Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
Nature Communications, Nature Publishing Group, 2018, 9, ⟨10.1038/s41467-018-06215-z⟩
Nature Communications, Nature Publishing Group, 2018, 9 (1), pp.4013. ⟨10.1038/s41467-018-06215-z⟩
Despite several clinical trials implemented, no antiviral drug could demonstrate efficacy against Ebola virus. In non-human primates, early initiation of polymerase inhibitors favipiravir and remdesivir improves survival, but whether they could be ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::d154ac0e471157d76dc4db477c6eb882
https://hal-pasteur.archives-ouvertes.fr/pasteur-03236192/document
https://hal-pasteur.archives-ouvertes.fr/pasteur-03236192/document
Autor:
Alba Llibre, Darragh Duffy
Publikováno v:
Comparative Immunology, Microbiology and Infectious Diseases
Comparative Immunology, Microbiology and Infectious Diseases, 2018, 59, pp.57-62. ⟨10.1016/j.cimid.2018.09.008⟩
Comparative Immunology, Microbiology and Infectious Diseases, Elsevier, 2018, 59, pp.57-62. ⟨10.1016/j.cimid.2018.09.008⟩
Comparative Immunology, Microbiology and Infectious Diseases, 2018, 59, pp.57-62. ⟨10.1016/j.cimid.2018.09.008⟩
Comparative Immunology, Microbiology and Infectious Diseases, Elsevier, 2018, 59, pp.57-62. ⟨10.1016/j.cimid.2018.09.008⟩
International audience; Biomarkers are increasingly utilised in biological research and clinical practice for diagnosis of disease, monitoring of therapeutic prognosis, or as end points in clinical studies. Cytokines are small molecules that orchestr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b32dd1d6637bb3160750736c8a06528
https://hal-pasteur.archives-ouvertes.fr/pasteur-01962505
https://hal-pasteur.archives-ouvertes.fr/pasteur-01962505
Publikováno v:
Journal of Visualized Experiments : JoVE
Llibre, A, Bondet, V, Rodero, M P, Hunt, D, Crow, Y J & Duffy, D 2018, ' Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α ', Journal of Visualized Experiments (JoVE), no. 136 . https://doi.org/10.3791/57421
Journal of visualized experiments : JoVE
Journal of visualized experiments : JoVE, 2018, 136, pp.e57421. ⟨10.3791/57421⟩
Journal of visualized experiments : JoVE, JoVE, 2018, pp.e57421. ⟨10.3791/57421⟩
Llibre, A, Bondet, V, Rodero, M P, Hunt, D, Crow, Y J & Duffy, D 2018, ' Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α ', Journal of Visualized Experiments (JoVE), no. 136 . https://doi.org/10.3791/57421
Journal of visualized experiments : JoVE
Journal of visualized experiments : JoVE, 2018, 136, pp.e57421. ⟨10.3791/57421⟩
Journal of visualized experiments : JoVE, JoVE, 2018, pp.e57421. ⟨10.3791/57421⟩
International audience; The main aim of this protocol is to describe the development and validation of an interferon (IFN)-α single molecule array digital Enzyme-Linked ImmunoSorbent Assay (ELISA) assay. This system enables the quantification of hum
Autor:
Christian Trepo, Michael P. Manns, David Wright, Jose Luis Calleja, Peter W. White, Chan-Loi Yong, Stanislas Pol, George Kukolj, Jerry O. Stern, Marc Bourlière, Maurizio Bonacini, Thomas Berg, Wulf Otto Boecher, Yves Benhamou, Gerhard G. Steinmann, Joe Scherer
Publikováno v:
Journal of Hepatology
Journal of Hepatology, Elsevier, 2011, 54 (6), pp.1114-22. ⟨10.1016/j.jhep.2010.08.040⟩
Journal of Hepatology, Elsevier, 2011, 54 (6), pp.1114-22. 〈10.1016/j.jhep.2010.08.040〉
Journal of Hepatology, Elsevier, 2011, 54 (6), pp.1114-22. ⟨10.1016/j.jhep.2010.08.040⟩
Journal of Hepatology, Elsevier, 2011, 54 (6), pp.1114-22. 〈10.1016/j.jhep.2010.08.040〉
International audience; BACKGROUND & AIMS: BI201335 is a highly specific and potent HCV protease inhibitor. This multiple rising dose trial evaluated antiviral activity and safety in chronic HCV genotype-1 patients. METHODS: Thirty-four treatment-na
Publikováno v:
Journal of Leukocyte Biology
Journal of Leukocyte Biology, Society for Leukocyte Biology, 2017, 101 (5), pp.1181-1190. ⟨10.1189/jlb.2A0416-187RR⟩
Journal of Leukocyte Biology, 2017, 101 (5), pp.1181-1190. ⟨10.1189/jlb.2A0416-187RR⟩
Journal of Leukocyte Biology, Society for Leukocyte Biology, 2017, 101 (5), pp.1181-1190. ⟨10.1189/jlb.2A0416-187RR⟩
Journal of Leukocyte Biology, 2017, 101 (5), pp.1181-1190. ⟨10.1189/jlb.2A0416-187RR⟩
Type I IFN can exert pro- and anti-inflammatory activities in the immune system. Here, we have investigated the mechanism by which IFN-α enhances early expression of the anti-inflammatory cytokine IL-10 in human CD45RA+CD4+ T cells. With the use of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ff2464e50cc98856b4358c2ff846e243
https://hal-pasteur.archives-ouvertes.fr/pasteur-02136992
https://hal-pasteur.archives-ouvertes.fr/pasteur-02136992
Autor:
José Alcamí, Nicoletta Casartelli, Bénédicte Vanwalscappel, Francisco Díez Fuertes, Sylvie Rato, Mayte Pérez-Olmeda, Fabrizio Mammano
Publikováno v:
Virology
Virology, Elsevier, 2017, 500, pp.247-258. ⟨10.1016/j.virol.2016.10.028⟩
Virology, 2017, 500, pp.247-258. ⟨10.1016/j.virol.2016.10.028⟩
Virology, Elsevier, 2017, 500, pp.247-258. ⟨10.1016/j.virol.2016.10.028⟩
Virology, 2017, 500, pp.247-258. ⟨10.1016/j.virol.2016.10.028⟩
International audience; Treatment of HIV-infected patients with IFN-α results in significant, but clinically insufficient, reductions of viremia. IFN induces the expression of several antiviral proteins including BST-2, which inhibits HIV by multipl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd54a6dde6550d72dae3de7a934f8bd6
https://hal-pasteur.archives-ouvertes.fr/pasteur-03253658
https://hal-pasteur.archives-ouvertes.fr/pasteur-03253658
Autor:
Caval, Mohamed S. Bouzidi, Jean-Pierre Vartanian, Michel Henry, Rodolphe Suspène, Simon Wain-Hobson
Publikováno v:
British Journal of Cancer
British Journal of Cancer, 2014, 110 (10), pp.2615-2622. ⟨10.1038/bjc.2014.176⟩
British Journal of Cancer, 2014, 110 (10), pp.2615-2622. ⟨10.1038/bjc.2014.176⟩
International audience; Background: The revolution in cancer genomics shows that the dominant mutations are CG->TA transitions. The sources of these mutations are probably two host cell cytidine deaminases APOBEC3A and APOBEC3B. The former in particu
Autor:
Renaud Mahieux, Nga Ling Ko, Chloé Journo, Sandrine Alais, Sébastien Chevalier, Hélène Dutartre, Lee Ratner, Anne Cachat
Publikováno v:
Journal of Virology
Journal of Virology, 2013, 87 (24), pp.13386-96. ⟨10.1128/JVI.02758-13⟩
Journal of Virology, American Society for Microbiology, 2013, 87 (24), pp.13386-96. ⟨10.1128/JVI.02758-13⟩
Journal of Virology, 2013, 87 (24), pp.13386-96. ⟨10.1128/JVI.02758-13⟩
Journal of Virology, American Society for Microbiology, 2013, 87 (24), pp.13386-96. ⟨10.1128/JVI.02758-13⟩
Type I interferon (IFN-I) inhibits the replication of different viruses. However, the effect of IFN-I on the human T-lymphotropic virus type 1 (HTLV-1) viral cycle is controversial. Here, we investigated the consequences of IFN-α addition for differ